Subcutaneous immunotherapy injections work the same way as their intravenous counterparts — by changing or enhancing a person’s immune responses to cancer. Immunotherapy for cancer is a broad ...

Subcutaneous immunotherapy injections for cancer, such as immune checkpoint inhibitors, are an emerging therapy that may replace some traditional intravenous infusions. Common side effects include ...

Twice-yearly lenacapavir comes as subcutaneous injections of 927 mg of the drug administered every half a year. For the once-yearly study, researchers at Gilead examined two intramuscular ...

Control mice were injected with aqueous vaccine using a 26.5-gauge needle. The subcutaneous injection was given in the scruff of the neck and the intramuscular injection was made in the upper thigh.

Currently, there is no cure or vaccine approved for HIV/AIDS ... a year underneath the skin and above the muscle tissue (subcutaneous injection). Results from the phase 3 trials, published ...

When topline phase III data was released in November, hinting at the potential of success, Jefferies analyst Akash Tiwari ...

A single shot of a new formulation of the antiretroviral drug lenacapavir could potentially provide protection against HIV ...

The Personalized Cancer Vaccine Summit, formerly known as ... A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared ...